What Know About Orbimed's Influence on Enliven's 130% Rally
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Discover whether stocks or bonds are better for achieving financial freedom. Start making smarter investment decisions today.
26,067 articlesA major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
New market data challenge the idea that AI spending is peaking. AI infrastructure is expanding, with implications for...
As the week nears its end, Thursday often brings a fresh wave of data and earnings that can move markets. This guide ...
Broadcom’s latest price move came on the back of a price-target cut and AI optimism colliding with caution. This guid...
A March 17, 2026 report from Muddy Waters Research targets SoFi Technologies, spurring volatility as KBW weighs in. S...
A high-profile return to release strategy reshapes expectations for both moviegoers and investors as the devil wears ...
Intel has powered a 492% surge in a year, but a wave of insider selling has traders weighing how durable the rebound ...
As bond markets flash warnings and oil risk climbs from Gulf tensions, a leading wall street strategist warns that th...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
An accessible analysis of what this $405,000 bj's insider sale means for investors, plus practical steps to read insi...
ARK Invest doubled down on SpaceX after a market pullback, funding the move by trimming Alibaba. The trade underscore...
YANG, the 3X inverse ETF tracking FTSE China 50, has fallen about 44% in the last year as Chinese large-caps rally. F...